About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gsk3atm1Dral
targeted mutation 1, Dario R Alessi
MGI:3578225
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gsk3atm1Dral/Gsk3atm1Dral involves: 129P2/OlaHsd * C57BL/6 MGI:3578280
cx2
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
involves: 129P2/OlaHsd MGI:5508810
cx3
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3578282
cx4
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
Gys1tm1.1Arte/Gys1tm1.1Arte
involves: 129P2/OlaHsd * C57BL/6J MGI:4882130


Genotype
MGI:3578280
hm1
Allelic
Composition
Gsk3atm1Dral/Gsk3atm1Dral
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gsk3atm1Dral mutation (1 available); any Gsk3a mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice showed no unusual phenotype

homeostasis/metabolism
N
• glucose and insulin levels were normal and mice were not glucose intolerant




Genotype
MGI:5508810
cx2
Allelic
Composition
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gsk3atm1Dral mutation (1 available); any Gsk3a mutation (18 available)
Gsk3btm1Dral mutation (1 available); any Gsk3b mutation (113 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• mice show increased susceptibility to amphetamine-induced hyperactivity
• after habituation to a novel open field environment, administration of amphetamine causes over 2.5-fold greater hyperactivity in mutants than in wild-type mice over a 30 minute period
• amphetamine shows a lower threshold for hyperactivity in mutants than in wild-type mice
• mutants show a 19 and 59% increase in hyperactivity after 2 and 3 weekly treatments with amphetamine compared to wild-type mice that do not show sensitization to this low-dose repeated administration
• while both wild-type and mutant mice show failure to escape foot shocks after conditioning with random, mild inescapable foot shocks, when the level of aversive stimuli is reduced to a level that does not cause failure to escape in wild-type mice, 91% of mutants fail to escape foot shocks, indicating increased susceptibility to stress-induced depressive-like behavior
• mutants exhibit a longer escape latency compared to wild-type mice and this behavior persists throughout 30 trials unlike in wild-type mice that show longer escape latency only in the first five trials
• in a fear conditioning paradigm, freezing time is 28% higher than in wild-type upon exposure to the contextual test 24 hours later
• upon exposure to a novel context (pretone cue test), mutants initially show 59% less freezing than wild-type mice
• however, when exposed to a tone paired with the new context, mutants exhibit normal freezing times, indicating intact amygdalar function
• mutants exhibit heightened response to novel environment, showing an initial increase in hyperactivity compared to wild-type mice when placed in an open field
• in the forced swim test and tail suspension test, mutants spend 29% and 27% more time, respectively, immobile than wild-type mice, indicating increased susceptibility to stress-induced depressive-like behaviors
• mutants show mild-anxious behavior in the elevated plus maze, spending 44% less time in the open arms of the maze and longer time in the closed arms of the maze than wild-type mice
• without previous conditioning by inescapable foot shocks, 32% of mutants fail to escape foot shocks compared to none in wild-type mice
• administration of lipopolysaccharide (LPS) 24 hours after aversive stress (foot shocks) results in an additional increase in immobility time
• mutants show only slight thigmotaxis in the open field during the first 5 minutes of testing but not overall throughout 15 minutes, indicating that a new environment may trigger anxiety
• mice exhibit hyperactivity in novel, but not familiar, environment; when mutants are placed in an open field, they initially show modest hyperactivity but are able to habituate to normal levels with repeat testing in the same open field
• chronic lithium administration partially reduces amphetamine-induced hyperactivity to the level equivalent to wild-type mice receiving amphetamine treatment

homeostasis/metabolism
• while baseline levels of corticosterone are similar to wild-type mice, immediately following an inescapable foot shock session, mutants exhibit increased serum corticosterone levels compared to wild-type
• lithium pretreatment results in serum corticosterone levels similar to wild-type mice following an inescapable foot shock session
• following escapable foot shock session, serum corticosterone levels are also increased but not as much as after inescapable foot shock
• administration of lipopolysaccharide (LPS) 24 hours after aversive stress (foot shocks) results in an increase in IL-6 serum levels compared to wild-type

nervous system
• NMDA receptor-dependent LTD induced by low frequency stimulation is converted to a slow onset LTP-like response in the hippocampus
• however, baseline synaptic transmission and paired pulse ratio are normal

immune system
• administration of lipopolysaccharide (LPS) 24 hours after aversive stress (foot shocks) results in an increase in IL-6 serum levels compared to wild-type




Genotype
MGI:3578282
cx3
Allelic
Composition
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gsk3atm1Dral mutation (1 available); any Gsk3a mutation (18 available)
Gsk3btm1Dral mutation (1 available); any Gsk3b mutation (113 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• glucose and insulin levels were normal and mice were not glucose intolerant
• liver glycogen levels were 2-3 times higher in fasted double homozygous mice than in fasted controls

liver/biliary system
• liver glycogen levels were 2-3 times higher in fasted double homozygous mice than in fasted controls




Genotype
MGI:4882130
cx4
Allelic
Composition
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
Gys1tm1.1Arte/Gys1tm1.1Arte
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gsk3atm1Dral mutation (1 available); any Gsk3a mutation (18 available)
Gsk3btm1Dral mutation (1 available); any Gsk3b mutation (113 available)
Gys1tm1.1Arte mutation (0 available); any Gys1 mutation (57 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• insulin-stimulated glycogen synthesis is decreased compared to in wild-type mice and Gys1tm1.1Arte homozygotes
• however, insulin treatment still results in an increase in glycogen synthesis





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory